These important data suggest that GAS5 could revert ABCB1-mediated ADR resistance in ER-positive BC cells (MCF7) via the miR-221–3p/DKK2 axis by repressing the Wnt/β-catenin pathway. Here, GAS5 is linked to breast cancer.